| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.067 | 0.03 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.62 | 0.03 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |